South Korea Endometriosis Treatment Market Size & Outlook
South Korea endometriosis treatment market, 2018-2030 (US$M)
Related Markets
South Korea endometriosis treatment market highlights
- The South Korea endometriosis treatment market generated a revenue of USD 28.0 million in 2022 and is expected to reach USD 82.4 million by 2030.
- The South Korea market is expected to grow at a CAGR of 14.4% from 2023 to 2030.
- In terms of segment, hormone therapy was the largest revenue generating treatment type in 2022.
- Hormone Therapy is the most lucrative treatment type segment registering the fastest growth during the forecast period.
Endometriosis treatment market data book summary
| Market revenue in 2022 | USD 28.0 million |
| Market revenue in 2030 | USD 82.4 million |
| Growth rate | 14.4% (CAGR from 2022 to 2030) |
| Largest segment | Hormone therapy |
| Fastest growing segment | Hormone Therapy |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pain Medication, Hormone Therapy |
| Key market players worldwide | Bayer AG, Pfizer Inc, AbbVie Inc, AstraZeneca PLC, ObsEva SA, Teva Pharmaceutical Industries Ltd, Zydus Lifesciences, Eli Lilly and Co, Astellas Pharma Inc |
Other key industry trends
- In terms of revenue, South Korea accounted for 2.3% of the global endometriosis treatment market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China endometriosis treatment market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 55.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Endometriosis Treatment Market Scope
Endometriosis Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Korea endometriosis treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to endometriosis treatment market will help companies and investors design strategic landscapes.
Hormone therapy was the largest segment with a revenue share of 85.71% in 2022. Horizon Databook has segmented the South Korea endometriosis treatment market based on pain medication, hormone therapy covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to South Korea endometriosis treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Korea endometriosis treatment market databook
-
Our clientele includes a mix of endometriosis treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea endometriosis treatment market , including forecasts for subscribers. This country databook contains high-level insights into South Korea endometriosis treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Korea endometriosis treatment market report size, by treatment type, 2018-2030 (US$M)
South Korea Endometriosis Treatment Market Outlook Share, 2022 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
